Skip to content

Executive Functioning and Mindfulness in Adults With Attention Deficit/Hyperactivity Disorder Imaging

Executive Functioning and Mindfulness in Adults With ADHD Imaging

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01629914
Acronym
EFMImaging
Enrollment
0
Registered
2012-06-28
Start date
2012-06-30
Completion date
2013-01-31
Last updated
2017-01-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Attention-deficit/Hyperactivity Disorder

Keywords

Attention-deficit/hyperactivity disorder, executive functioning, mindfulness meditation, magnetic resonance imaging, healthy

Brief summary

The main purpose of this study is to evaluate changes in brain functioning using an MRI machine following mindfulness meditation training.

Detailed description

The broad objective of this proposal is to identify functional neuroanatomical correlates of changes in executive brain functioning prior to and following an 8-week, group-based mindfulness meditation intervention within a group of 10 adults diagnosed with Attention-deficit/hyperactivity disorder (ADHD). Another group of 10 adults diagnosed with ADHD will be placed in the waitlist condition. Our primary hypothesis is that adults with ADHD in the treatment group will exhibit improved performance on a series of executive functioning tasks and that exposure to task stimuli will correspond to changes in neural functioning following an 8-week, group-based mindfulness intervention. Brain responses will be measured using blood-oxygenation-level-dependent (BOLD) fMRI signal in brain regions associated with emotional and executive processes prior to and following treatment.

Interventions

BEHAVIORALMindfulness Meditation

8-week, group-based mindfulness meditation intervention

Sponsors

Duke University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* ages 18-50 years * meet DSM-IV criteria for ADHD * intellectual functioning ≥ 80 as assessed by an IQ screener * generally healthy (i.e., no major medical problems)

Exclusion criteria

* major medical condition that would make participation unsafe (e.g., have pacemaker or other metallic implant), uncomfortable (e.g., chronic pain) * claustrophobic, or abnormally afraid of closed-in places * current drug use

Design outcomes

Primary

MeasureTime frameDescription
change from baseline in blood-oxygenation-level-dependent (BOLD) fMRI signalbaseline and 8-weeksParticipants will be scanned prior to and following an 8-week group-based mindfulness meditation intervention

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026